Advanced molecular insights are transforming pancreatic cancer care. Learn how biomarker-defined clinical trials and targeted therapy combinations are setting new regulatory benchmarks worldwide, seamlessly navigated through Zenovel’s end-to-end GxP compliance, sponsor oversight, and global reach.